Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03502980
Other study ID # 7749
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 1, 2018
Est. completion date July 21, 2022

Study information

Verified date August 2021
Source Centre hospitalier de l'Université de Montréal (CHUM)
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to assess the non-inferiority for safety and efficacy of using Midline in comparison with PICC for intravenous therapy that do not require a central catheter.


Description:

Vascular access devices (VADs), including peripherally inserted central venous catheters (PICCs) remain a cornerstone for the delivery of necessary intravenous therapy. PICCs are being selected for venous access more frequently today than ever before. The advantage of PICC is that it can be used for all intravenous therapy. However, PICC requires the use of fluoroscopy or other type of guidance which add to the cost and time required to insert the catheter. Midline, on the other hand, can be inserted under ultrasound guidance, takes less time to be inserted and cost less than PICC insertion. Despite lower cost and better accessibility of midline in comparison with PICC for non-vesicant intravenous therapy, there is very little evidence in the literature to suggest that one type of venous access is better than the other. The primary objective of this study is to assess the non-inferiority for safety and efficacy of using Midline in comparison with PICC for intravenous therapy that do not require a central catheter. Results of this trial will allow improving a quality of evidence for using midline instead of PICC for specified indications. If Midline are non-inferior for some indications, they would represent a more accessible and less expensive alternative than PICC insertion.


Recruitment information / eligibility

Status Completed
Enrollment 293
Est. completion date July 21, 2022
Est. primary completion date July 21, 2022
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Required intra venous therapy - Expected duration of the venous access: > 6 days and < 30days Exclusion Criteria: - Patient has a contraindication to insertion of either a Midline or a PICC relative to the therapy - Patient from other hospitals who come to the CHUM only for the installation of a central line - Decreased cognitive ability to care for device at home - Preexisting bacteremia (ie, existing positive blood cultures that had not been repeated with negative results) - Preexisting venous thrombosis or known hypercoagulable states (such as protein C or S deficiency, antithrombin deficiency, lupus anticoagulant) - Venous access with multiple lumens required - Patients not able to give informed consent - Prior participation to this study - Patient is enrolled in another investigational study - Patients hospitalized in the intensive care unit - Patients who are difficult to puncture and require multiple blood samples

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Bard PowerPICC
PICC Insertion
Bard PowerMidline catheter
Midline Insertion

Locations

Country Name City State
Canada Centre hospitalier de l'université de Montréal Montreal Quebec

Sponsors (1)

Lead Sponsor Collaborator
Centre hospitalier de l'Université de Montréal (CHUM)

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary % of patients without VAD-related adverse event requiring medical intervention Infections, Thrombophlebitis, Infiltration, Bleeding, Pain, Death Until 1 week after VAD retrieval
Primary % of patients whose intended or additional I.V treatments could be completed with the VAD without VAD complications, dysfunctions or limitations (ex: need for central access or for additional peripheral or central lumens/catheters) Until 1 week after VAD retrieval
Secondary % of patients who experience VAD-related adverse events requiring medical intervention Infections, Thrombophlebitis, Infiltration, Bleeding, Pain, Death Until 1 week after VAD retrieval
Secondary Number of VAD-related adverse events requiring medical intervention per 1000 catheter/days Until 1 week after VAD retrieval
Secondary Time to first VAD-related adverse events Until 1 week after VAD retrieval
Secondary Duration VAD intervention (Midline or PICC) Index procedure
Secondary Number of additional interventions to insert the VAD Index procedure
Secondary % of patients who required another VAD to complete the intended or additional iv treatments, either because of VAD complications, dysfunctions or limitations Until 1 week after VAD retrieval
Secondary % of patient without failed blood sampling attempts through the VAD Until 1 week after VAD retrieval
Secondary % of patients for whom the end of treatment was the reason for VAD retrieval Until 1 week after VAD retrieval
See also
  Status Clinical Trial Phase
Recruiting NCT03801811 - Use of the Skin Glue in the Placement of Central Venous Catheters Port a Catch
Completed NCT02888431 - Correlation of Arterial and Venous Lactate and Base Deficit Values N/A
Completed NCT03647293 - Less Pain in Neonates During Central Lines Insertion N/A
Completed NCT02009189 - Taurolidine Lock in Long Term Parenteral Nutrition Phase 4
Completed NCT05124821 - Evaluation of Performance Over Dwell Time and Safety of the Central-venous Catheters Certofix® Paed
Completed NCT03025178 - Optimal Insertion Depth of Left Internal Jugular Vein Catheter in Infants N/A
Not yet recruiting NCT05751395 - Siting Central Venous Catheters Precisely While Performing the Access Procedure
Completed NCT04630236 - Ultrasound Guided Positioning of Central Venous Catheters N/A
Not yet recruiting NCT06451185 - Statseal® for Central Venous Catheter Insertion Sites in Critical Care N/A
Completed NCT05176886 - Correct Tip Position of Central Venous Catheters
Recruiting NCT05956028 - Efficacy of Ultrasound-guided Internal Jugular Vein Versus Supraclavicular Subclavian Vein Cannulation in Neonates and Infants Less Than 5 kg. N/A
Active, not recruiting NCT02472132 - The Use of Point of Care Ultra Sound for Correct Placement of Central Venous Catheter N/A
Completed NCT02314520 - Complications Associated With Central Venous Access in the NSICU: PICC vs CVC N/A
Completed NCT00903539 - Prospective SecurAcath Subcutaneous Securement Trial N/A
Completed NCT04117776 - Skin Decolonization of Children Hospitalized in Intensive Care Unit
Completed NCT03879954 - US-guided OOP Internal Jugular Vein Vs IP Supraclavicular Subclavian Vein Catheterization in ICU N/A
Completed NCT04733547 - Spectral Analysis of Central Venous Pressure Waveform
Completed NCT04637347 - SC vs IC Approach for US-guided SC Vein Catheterization N/A
Completed NCT03109574 - Access in Dialysis for Better Outcomes in Patient Therapy N/A
Completed NCT04597021 - Wireless US-guided CVC Placement in Infants